Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-23

FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk, resulting in changes to the product labeling as requested in the su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levemir (insulin detemir)

Snippet

SUPPL AP for LEVEMIR (INSULIN DETEMIR)